Back to trial details

Intake questionnaire

A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

Applying to Thomas Jefferson University · Philadelphia, Pennsylvania

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Non Small Cell Lung Cancer?
3. Are you able to travel to Philadelphia for study visits?